Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined Antihistaminics Therapy in COVID-19
NCT05043350Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- Sep 2021
- Primary completion
- Jul 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of loratadine in coronavirus disease 2019 (COVID-19), sponsored by Ain Shams University. Started Sep 2021; status: completed.
02
Drugs
loratadine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05043350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05043350.